Low-volume plasma exchange for liver failure
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether giving a smaller amount of a blood-cleaning treatment (plasma exchange) can help people with sudden liver failure on top of long-term liver disease. It aims to improve liver function and overall outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have liver failure that happened suddenly because of chronic liver disease, with high bilirubin and a blood clotting test (INR) above 1.5.
- Your liver failure is at a stage 1 or 2 (not the most severe stage).
- You do not have cancer, are not pregnant or breastfeeding, and do not have HIV or other immune problems.
- You have not had a organ transplant and are not in end-stage organ failure (like needing dialysis or a ventilator).
- Your platelet count is at least 50 × 10⁹/L, and you do not have severe bleeding or a serious allergy to the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure that cleans your blood (called plasma exchange) given at half the usual dose, along with other detox methods, to help people with sudden liver failure. It aims to help your liver recover or support you while you wait for a transplant.
This study tests a treatment that cleans your blood to help your liver recover if you have sudden liver failure. It may improve your chances of getting better.
This trial tests a new liver dialysis device called DIALIVE 2.0 for people with acute-on-chronic liver failure (a sudden, severe worsening of chronic liver disease). If you qualify, the device will help filter your blood, similar to kidney dialysis, to support your liver while it tries to recover.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
This trial tests whether a treatment called plasma exchange (which removes harmful substances from your blood and replaces them with healthy plasma) can help improve the function of other organs, like the kidneys or lungs, in people with advanced liver failure. It aims to find out if this treatment helps you recover better and to identify markers that show if the treatment is working.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
Hear when a new Acute on Chronic Liver Failure (ACLF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.